特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

医療研究受託の世界市場 - 調査および予測

Global Healthcare Contract Research Market Research and Forecast, 2019-2025

発行 Orion Market Research Pvt Ltd 商品コード 839588
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.98円で換算しております。
医療研究受託の世界市場 - 調査および予測 Global Healthcare Contract Research Market Research and Forecast, 2019-2025
出版日: 2019年05月06日 ページ情報: 英文
概要

当レポートでは、医療研究受託の世界市場に注目し、その全体像と発展性を探るべく、取引規模の予測数値を市場セグメントおよび地域の別に示すほか、経済全般を背景とした発展推進・抑制要因・機会など、直接取材および二次情報調査・分析から得られたファクト、市場参入企業の事業展開や競合状況に関する最新の調査情報を提供します。

第1章 レポートサマリー

  • 調査の方法とツール
  • 市場分析
    • セグメント別
    • 地域別
    • ステークホルダー別

第2章 市場の概要と考察

  • 定義
  • アナリストによる考察と現在の市場動向
    • 重要所見
    • 提言
    • 結論
  • 関連法と規制

第3章 競合環境

競合ダッシュボード 重要施策分析 主要企業分析

第4章 市場決定要因

  • 推進要因
  • 制約要因
  • 発展機会

第5章 市場セグメンテーション

  • 医療研究受託の世界市場 - サービス別
    • 創薬・薬剤開発
    • 前臨床サービス
    • 臨床サービス
    • リスク管理・市販後医薬品安全性監視
    • データ管理・技術サービス
    • 市販後・コンサルティングサービス
    • その他のサービス(ラボサービス、プロジェクト管理など)
  • 医療研究受託の世界市場 - 治療分野別
    • 心臓病学
    • がん治療
    • 神経学
    • 呼吸器疾患
    • 自己免疫疾患
    • その他(血液学、婦人科など)

第6章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋州
    • 中国
    • インド
    • 日本
    • その他アジア太平洋州
  • その他の地域

第7章 企業プロフィール

  • Charles River Laboratories International Inc. (CRL)
  • Clinipace, Inc.
  • Fisher Clinical Services, Inc.
  • GVK Biosciences Pvt., Ltd.
  • HCL Technologies, Ltd.
  • ICON, PLC
  • IQVIA Holdings, Inc.
  • JLL Partners, LLC
  • LabCorp (Covance)
  • Lambda Therapeutic Research, Ltd.
  • Medelis, Inc.
  • Medpace, Inc.
  • PAREXEL International Corp.
  • Pharmaceutical Product Development, LLC
  • Pharmaron Beijing Co., Ltd.
  • PRA Health Sciences, Inc.
  • Premier Research International, LLC
  • QPS Holdings, LLC
  • Syneos Health, Inc.
  • Synteract, Inc.
  • Worldwide Clinical Trials Holdings, Inc.
図表

List of Tables

  • 1. GLOBAL HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY SERVICE, 2018-2025 ($ MILLION)
  • 2. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL PRE-CLINICAL SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL CLINICAL SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL RISK MANAGEMENT & PHARMACOVIGILANCE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL DATA MANAGEMENT & TECHNOLOGY SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL POST MARKETING & CONSULTING SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 8. GLOBAL OTHER SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS AREA, 2018-2025 ($ MILLION)
  • 10. GLOBAL CARDIOVASCULAR DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL AUTOIMMUNE DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL RESPIRATORY DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. GLOBAL ONCOLOGY DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 14. GLOBAL NEUROLOGY DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 15. GLOBAL OTHER DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 16. GLOBAL HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 17. NORTH AMERICAN HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 18. NORTH AMERICAN HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY SERVICE, 2018-2025 ($ MILLION)
  • 19. NORTH AMERICAN HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC AREA, 2018-2025 ($ MILLION)
  • 20. EUROPEAN HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 21. EUROPEAN HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY SERVICE, 2018-2025 ($ MILLION)
  • 22. EUROPEAN HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC AREA, 2018-2025 ($ MILLION)
  • 23. ASIA-PACIFIC HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 24. ASIA-PACIFIC HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY SERVICE, 2018-2025 ($ MILLION)
  • 25. ASIA-PACIFIC HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC AREA, 2018-2025 ($ MILLION)
  • 26. REST OF THE WORLD HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY SERVICE, 2018-2025 ($ MILLION)
  • 27. REST OF THE WORLD HEALTHCARE CRO MARKET RESEARCH AND ANALYSIS BY THERAPEUTIC AREA, 2018-2025 ($ MILLION)

List of Figures

  • 1. GLOBAL HEALTHCARE CRO MARKET SHARE BY SERVICE, 2018 VS 2025 (%)
  • 2. GLOBAL HEALTHCARE CRO MARKET SHARE BY THERAPEUTIC AREA, 2018 VS 2025 (%)
  • 3. GLOBAL HEALTHCARE CRO MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. REST OF EUROPE HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD HEALTHCARE CRO MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2019654

Global Healthcare Contract Research Organizations (CRO) Market, Size, Share & Trends Analysis Report, By Services (Drug Discovery & Development, Pre-Clinical Services, Clinical Services, Risk Management & Pharmacovigilance, and Others Services), By Therapeutic Area (Cardiology, Autoimmune Diseases, Oncology, Neurology, Respiratory Diseases and Others) and Forecast, 2019-2025

Healthcare CRO market has significant scope in pharmaceutical, biotechnology, and medical device industry since it reduces cost and time for clinical trial and drug development. CROs offers capabilities, for the growth of drug development, which includes pre-clinical R&D, clinical trials, monitoring and management, data management and analysis, study design, bio-statistical analysis, post-marketing surveillance, consulting, regulatory and safety assessment, and other services. The pharmaceutical companies, increasingly outsourcing critical functions, such as manufacturing and research. Use of CROs to lead clinical trials and develop new medications has been increased over the years.

Moreover, the major factors that are contributing towards the growth of the healthcare CRO market include rising demand for CRO, from pharmaceutical, biopharmaceutical, and medical device industries. Additionally, increasing outsourcing of R&D programs, rising R&D expenditures and growing number of clinical trials will drive the healthcare CRO market in near future. The CRO collaborations with government agencies and non-profit health organizations allows to expand clinical service providers, new drug development process and offers advanced healthcare outcomes. The CRO is considered as more affordable for companies to track new medications, however, pre-pursuing a drug approval is too expensive, and usually occurred as guaranteed approval for large markets. The presence of CROs is more cost-effective and allows companies to develop small drugs for niche audiences.

There are various companies involved in healthcare CRO market which includes Lambda Therapeutic Research, Ltd., PAREXEL International Corp., Pharmaceutical Product Development (PPD), LLC, Pharmaron Beijing Co., Ltd., LabCorp, and Syneos Health. Merger & acquisition, geographical expansion, finding a new market or innovate in their core competency in order to expand individual market share is a key strategy adopted by major market players. For instance, in July 2017, LabCorp acquired Chiltern International, Ltd., which allows the company to strengthen its position as a global life sciences company with diagnostics and drug development businesses. The acquisition supports achieving a significant global scale. Chiltern International, Ltd., becomes the company's Covance Drug Development business unit and expected to expand Covance offerings through focusing high-growth emerging and mid-market biopharma segments. The strategy of the company is to quickly offer innovative oncology medicine to a patient, that enables to improve patient outcomes. Geographically, the market is divided into North America, Europe, Asia-Pacific and Rest of the World (RoW). Asia-Pacific demonstrates considerable potentials for collaborative and outsourced R&D in drug development, biotechnology, and medical devices. The increasing government initiatives, to promote the pharmaceutical sector, as it outsources the clinical development process to specialized CRO in the region enables to expand the CRO market.

Research Methodology

The market study of the global healthcare CRO market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authentic public databases such as the IBEF, IFPMA, and others
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog.

The report is intended for research organizations, dental laboratories, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market Segmentation:

  • 1. Global Healthcare CRO Market Research and Analysis by Service
  • 2. Global Healthcare CRO Market Research and Analysis by Therapeutic Area

The Report Covers:

  • Comprehensive research methodology of the global healthcare CRO market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global healthcare CRO market.
  • Insights about market determinants which are stimulating the global healthcare CRO market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Competitive Dashboard
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Laboratory Corporation of America Holdings (LabCorp)
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Charles River Laboratories International, Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. PRA Health Sciences, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. IQVIA Holdings, Inc.
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Syneos Health
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Healthcare CRO Market by Service
    • 5.1.1. Drug Discovery & Development
    • 5.1.2. Pre-Clinical Services
    • 5.1.3. Clinical Services
    • 5.1.4. Risk Management & Pharmacovigilance
    • 5.1.5. Data Management & Technology Services
    • 5.1.6. Post Marketing and Consulting Services
    • 5.1.7. Other Services (Laboratory Services and Project Management)
  • 5.2. Global Healthcare CRO Market by Therapeutic Area
    • 5.2.1. Cardiology
    • 5.2.2. Oncology
    • 5.2.3. Neurology
    • 5.2.4. Respiratory Diseases
    • 5.2.5. Autoimmune Diseases
    • 5.2.6. Others (Hematology & Gynecology)

6. REGIONAL ANALYSIS

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. COMPANY PROFILES

  • 7.1. Charles River Laboratories International Inc. (CRL)
  • 7.2. Clinipace, Inc.
  • 7.3. Fisher Clinical Services, Inc.
  • 7.4. GVK Biosciences Pvt., Ltd.
  • 7.5. HCL Technologies, Ltd.
  • 7.6. ICON, PLC
  • 7.7. IQVIA Holdings, Inc.
  • 7.8. JLL Partners, LLC
  • 7.9. LabCorp (Covance)
  • 7.10. Lambda Therapeutic Research, Ltd.
  • 7.11. Medelis, Inc.
  • 7.12. Medpace, Inc.
  • 7.13. PAREXEL International Corp.
  • 7.14. Pharmaceutical Product Development, LLC
  • 7.15. Pharmaron Beijing Co., Ltd.
  • 7.16. PRA Health Sciences, Inc.
  • 7.17. Premier Research International, LLC
  • 7.18. QPS Holdings, LLC
  • 7.19. Syneos Health, Inc.
  • 7.20. Synteract, Inc.
  • 7.21. Worldwide Clinical Trials Holdings, Inc.